Effectors of dipeptidyl peptidase IV

US6548481B1 · kind B1 · utility

Assignee

• PROBIODRUG AG · DE

Inventors

• Hans-Ulrich Demuth · Halle (Saale), DE
• Konrad Glund · Halle (Saale), DE
• Dagmar Schlenzig · Bodenwerder, DE
• Susanne Kruber · Bornheim, DE

Key dates

• Filing date: Nov 28, 2000
• Grant date: Apr 15, 2003
• Expiry date: Nov 28, 2020

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D277/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Dipeptide compounds and compounds analogous to dipeptide compounds that are formed from an amino acid and a thiazolidine or pyrrolidine group, and salts thereof used in the treatment of impaired glucose tolerance, glycosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and also of sequelae of diabetes mellitus in mammals.